Connection
Edward Havranek to Adenosine A1 Receptor Antagonists
This is a "connection" page, showing publications Edward Havranek has written about Adenosine A1 Receptor Antagonists.
|
|
Connection Strength |
|
 |
|
 |
|
0.074 |
|
|
|
-
Greenberg B, Thomas I, Banish D, Goldman S, Havranek E, Massie BM, Zhu Y, Ticho B, Abraham WT. Effects of multiple oral doses of an A1 adenosine antagonist, BG9928, in patients with heart failure: results of a placebo-controlled, dose-escalation study. J Am Coll Cardiol. 2007 Aug 14; 50(7):600-6.
Score: 0.074